Design and characterization of a novel prostate-specific membrane antigen-targeted radioligand modified with a fatty acid albumin binder for optimized circulation half-life

Shaomei Zeng(Buchang Pharma (China)), Jun Tang(Craft Group (China)), Xiang Gao(Sir Run Run Shaw Hospital), Xudong Yang(Changchun University of Technology), Yao Zhang(Buchang Pharma (China)), Yi Zhang, Ping Zhou(Central South University), Meng Jiang(Buchang Pharma (China)), Xiaodong Zhang(Qingdao University), Yuanqing Tang(Chengdu Organic Chemicals (China)), Min Li(Buchang Pharma (China)), Z.W. Su(Chengdu Organic Chemicals (China))
EJNMMI Radiopharmacy and Chemistry
September 26, 2025
10.1186/s41181-025-00385-0
Cited by 3

Related Papers

Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
|Nature|2015|827
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
|Proceedings of the National Academy of Sciences|2011|379
Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy
|Cell|2020|288
pH- and Temperature-Sensitive Hydrogel Nanoparticles with Dual Photoluminescence for Bioprobes
|ACS Nano|2016|242
A complex structure of arrestin-2 bound to a G protein-coupled receptor
|Cell Research|2019|230